These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 25797801)
1. The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension. DeSouza SA; Preston IR Expert Rev Cardiovasc Ther; 2015 May; 13(5):467-76. PubMed ID: 25797801 [TBL] [Abstract][Full Text] [Related]
2. Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension. Lian TY; Jiang X; Jing ZC Drug Des Devel Ther; 2017; 11():1195-1207. PubMed ID: 28458514 [TBL] [Abstract][Full Text] [Related]
3. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Bishop BM Am J Health Syst Pharm; 2014 Nov; 71(21):1839-44. PubMed ID: 25320133 [TBL] [Abstract][Full Text] [Related]
4. Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Dasgupta A; Bowman L; D'Arsigny CL; Archer SL Clin Pharmacol Ther; 2015 Jan; 97(1):88-102. PubMed ID: 25670386 [TBL] [Abstract][Full Text] [Related]
5. Riociguat: first global approval. Conole D; Scott LJ Drugs; 2013 Nov; 73(17):1967-75. PubMed ID: 24218053 [TBL] [Abstract][Full Text] [Related]
6. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Mielniczuk LM; Swiston JR; Mehta S Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043 [TBL] [Abstract][Full Text] [Related]
7. Riociguat for the treatment of pulmonary hypertension. Hambly N; Granton J Expert Rev Respir Med; 2015; 9(6):679-95. PubMed ID: 26599488 [TBL] [Abstract][Full Text] [Related]
11. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension. Garnock-Jones KP Drugs; 2014 Nov; 74(17):2065-78. PubMed ID: 25352393 [TBL] [Abstract][Full Text] [Related]
12. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. Ghofrani HA; D'Armini AM; Grimminger F; Hoeper MM; Jansa P; Kim NH; Mayer E; Simonneau G; Wilkins MR; Fritsch A; Neuser D; Weimann G; Wang C; N Engl J Med; 2013 Jul; 369(4):319-29. PubMed ID: 23883377 [TBL] [Abstract][Full Text] [Related]
15. Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension. Belik J Curr Opin Investig Drugs; 2009 Sep; 10(9):971-9. PubMed ID: 19705340 [TBL] [Abstract][Full Text] [Related]
16. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Simonneau G; D'Armini AM; Ghofrani HA; Grimminger F; Hoeper MM; Jansa P; Kim NH; Wang C; Wilkins MR; Fritsch A; Davie N; Colorado P; Mayer E Eur Respir J; 2015 May; 45(5):1293-302. PubMed ID: 25395036 [TBL] [Abstract][Full Text] [Related]
17. Riociguat: a novel new drug for treatment of pulmonary hypertension. Makowski CT; Rissmiller RW; Bullington WM Pharmacotherapy; 2015 May; 35(5):502-19. PubMed ID: 26011143 [TBL] [Abstract][Full Text] [Related]
18. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry. Ghofrani HA; Gomez Sanchez MA; Humbert M; Pittrow D; Simonneau G; Gall H; Grünig E; Klose H; Halank M; Langleben D; Snijder RJ; Escribano Subias P; Mielniczuk LM; Lange TJ; Vachiéry JL; Wirtz H; Helmersen DS; Tsangaris I; Barberá JA; Pepke-Zaba J; Boonstra A; Rosenkranz S; Ulrich S; Steringer-Mascherbauer R; Delcroix M; Jansa P; Šimková I; Giannakoulas G; Klotsche J; Williams E; Meier C; Hoeper MM; Respir Med; 2021 Mar; 178():106220. PubMed ID: 33540340 [TBL] [Abstract][Full Text] [Related]
19. [Riociguat - a stimulator of soluble guanylate cyclase: a new mode of action helps patients with pulmonary hypertension]. Kreutzkamp B Med Monatsschr Pharm; 2013 Dec; 36(12):442-7. PubMed ID: 24450268 [No Abstract] [Full Text] [Related]
20. Riociguat for the treatment of pulmonary hypertension. Schermuly RT; Janssen W; Weissmann N; Stasch JP; Grimminger F; Ghofrani HA Expert Opin Investig Drugs; 2011 Apr; 20(4):567-76. PubMed ID: 21391889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]